NCT07444723 2026-03-18
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
National Institutes of Health Clinical Center (CC)
Phase 2/3 Not yet recruiting
Clinical Trials
50 trialsNCT07460232 2026-03-10
FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
Mayo Clinic
Phase EARLY_PHASE1 Not yet recruiting
NCT07453225 2026-03-05
Empirical Radioactive Iodine Therapy in DTC
Assiut University
Phase 1/2 Not yet recruiting
NCT07450287 2026-03-04
CardioNETPOL
National Institute of Cardiology, Warsaw, Poland
Not yet recruiting
NCT07440290 2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3 Not yet recruiting
NCT06941480 2026-02-19
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
Memorial Sloan Kettering Cancer Center
Phase 1 Not yet recruiting
NCT06822751 2026-02-17
FOMUTI
University Hospital, Rouen
Phase 3 Not yet recruiting
NCT07376837 2026-01-29
PTC-RFA
University Health Network, Toronto
Phase NA Not yet recruiting
NCT07373015 2026-01-28
Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase NA Not yet recruiting
NCT07366658 2026-01-26
NEUK203-13
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Not yet recruiting
NCT07354698 2026-01-21
MHI
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 4 Not yet recruiting
NCT07337447 2026-01-13
REWENEC 01
Hospices Civils de Lyon
Phase 2 Not yet recruiting
NCT07316101 2026-01-05
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
West China Hospital
Phase NA Not yet recruiting
NCT07102056 2025-12-29
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
First Affiliated Hospital of Zhejiang University
Not yet recruiting
NCT07306325 2025-12-29
Ultrasound in Predicting Difficult Intubation in Acromegaly Patients
Başakşehir Çam & Sakura City Hospital
Not yet recruiting
NCT07274657 2025-12-10
SMILE
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase NA Not yet recruiting
NCT07258810 2025-12-02
ETP-NET
Hospices Civils de Lyon
Not yet recruiting
NCT07252661 2025-11-28
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
AccSalus Biosciences, Inc.
Phase 1 Not yet recruiting
NCT07200245 2025-10-01
HEMODYNAMICS
Central Hospital, Nancy, France
Not yet recruiting
NCT07192991 2025-09-25
NECTARINE
Latin American Cooperative Oncology Group
Not yet recruiting
NCT07165132 2025-09-10
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RayzeBio, Inc.
Phase 1 Not yet recruiting
NCT07156019 2025-09-04
Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT07141147 2025-09-03
A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.
Sun Yat-sen University
Phase NA Not yet recruiting
NCT07138261 2025-08-22
TATC
National Health Research Institutes, Taiwan
Not yet recruiting
NCT07042984 2025-06-29
RET-US
Fujian Medical University
Not yet recruiting
NCT07014254 2025-06-10
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
Xijing Hospital
Phase NA Not yet recruiting
NCT06266949 2025-05-02
Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors
University Medical Center Groningen
Not yet recruiting
NCT06730893 2025-04-30
MAeSTro-SDM
National Cancer Center, Korea
Phase NA Not yet recruiting
NCT06951243 2025-04-30
A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer
Beijing GoBroad Hospital
Phase 2 Not yet recruiting
NCT06936735 2025-04-20
Phase I Study of HS-20108 in Participants With Advanced Solid Tumors
Hansoh BioMedical R&D Company
Phase 1 Not yet recruiting
NCT06901856 2025-03-30
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
Guangdong Provincial People's Hospital
Phase NA Not yet recruiting
NCT06899347 2025-03-27
PRO-COMAND
University of Pisa
Phase NA Not yet recruiting
NCT06816394 2025-02-10
TAURUS
National Taiwan University Hospital
Phase 2 Not yet recruiting
NCT06804863 2025-02-03
Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer
West China Hospital
Phase NA Not yet recruiting
NCT06764368 2025-01-08
Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors
Beijing Chest Hospital
Phase 2 Not yet recruiting
NCT06713304 2024-12-16
A Community-Based Intervention to Reduce Alcohol Use in Vietnamese Men
Chulalongkorn University
Phase NA Not yet recruiting
NCT06725628 2024-12-10
Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma
Zhejiang Chinese Medical University
Not yet recruiting
NCT06701838 2024-12-03
OPTIMAL
Imperial College London
Not yet recruiting
NCT06626581 2024-10-04
Iodine Status and Characteristics of Papillary Thyroid Cancer
Shandong Provincial Hospital
Not yet recruiting
NCT06607198 2024-09-23
PitNET2024
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting
NCT06556186 2024-08-15
Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Not yet recruiting
NCT06326853 2024-06-11
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models
IRCCS San Raffaele
Not yet recruiting
NCT06408402 2024-05-10
PGLEXPO2
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
NCT06344832 2024-04-03
SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs
Peking Union Medical College Hospital
Not yet recruiting
NCT04889742 2023-12-26
HETERERO
Charite University, Berlin, Germany
Phase 2 Not yet recruiting
NCT06156332 2023-12-05
A Study of Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy
Shanghai Changzheng Hospital
Phase NA Not yet recruiting
NCT05967481 2023-08-01
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
Power Life Sciences Inc.
Not yet recruiting
NCT05894486 2023-06-08
Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors
Peking University
Phase 2 Not yet recruiting
NCT05819593 2023-04-19
Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences
Power Life Sciences Inc.
Not yet recruiting
NCT04788927 2023-04-07
PPGL-Pred
Rigshospitalet, Denmark
Not yet recruiting